We have investigated the following pulmonary related parameters in 22 patients with Crohn's disease who were free of clinical pulmonary symptoms and had normal chest roentgenograms and in 25 controls: serum angiotensin converting enzyme, pulmonary function tests, bronchoalveolar lavage (lymphocyte count and subpopulations, macrophage viability and superoxide anion release by macrophages) and pulmonary scannings. Serum angiotensin converting enzyme was lower in Crohn's disease (14-1±5 1) than in controls (25-2±4-7) (p<O-OO1). Twelve of 22 Crohn's disease (54%) had a bronchoalveolar lavage lymphocytosis (>18% alveolar lymphocytes). Bronchoalveolar lavage lymphocytes subpopulations were quite variable. Twelve of 17 Crohn's disease (71%) had an increase spontaneous and/or stimulated superoxide anion production by alveolar macrophages. Six of 12 Crohn's disease (50%) had an increase physiologic dead space in the upper part of their lung against one of 11 controls (9%). These data suggest that most patients with Crohn's disease have a latent pulmonary involvement.
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Systemic manifestations are frequent in inflammatory bowel disease, but classically the lung was regarded as rarely involved. 1 2 A few recent reports, however, have described pulmonary manifestations occuring in patients with inflammatory bowel disease: bronchial suppuration, or bronchiectasis, [3] [4] [5] granulomatous lung disease,6 diffuse or localised interstitial fibrosis71-2 and sulphasalazine pneumonitis. 1321 The rarity of pulmonary clinical manifestations contrasts with striking abnormalities of pulmonary function tests described in patients with inflammatory bowel disease: reduced lung transfer factor, increased residual volume, or decreased forced expiratory volume in one second.22 26 We have attempted to determine the actual frequency of pulmonary tests and bronchoalveolar abnormalities in patients with Crohn's disease and without clinical or radiological pulmonary the pulmonary abnormalities mechanism by carrying out pulmonary scintigraphic studies in those patients.
Methods

PATIENTS
Twenty two patients with Crohn's disease were included in the study. There were 11 women and 11 men, 18-44 years old (mean age 28±7-8 years). Eleven were cigarette smokers. None had a previous history of pulmonary disease or chest radiograph abnormalities. Physical examination and chest radiographs were normal in all patients at the time of the study. The length of Crohn's disease history at the onset of the study ranged from one month to 22 years (mean duration 41±57 months). Small bowel alone was involved in one case, colon alone in nine cases, and the localisations were multiple in 12 patients (stomach, small bowel, colon, rectum, anus). Eight patients had active anal Crohn's disease and 10 systemic manifestations: arthralgia (five), ankylosing spondylitis (three), aphtous ulcers (two).
Mean Crohn's Disease Activity Index (CDAI) was 207±86 (50-383). Six patients had quiescent disease (CDAI<150) at the time of the study. Four patients had received sulphasalazine (1.5 g-3 g/day for the previous three months to three years), one prednisolone (0-5 mg/kg body weight for the previous three weeks) and 10 metronidazole (1 g-1-5 g/day for the previous three months).
CONTROL SUBJECTS
The control group included hospital staff and other healthy volunteers. There were 25 controls subjects for bronchoalveolar lavage (13 were cigarette smokers), nine women and 16 men, Accumulation of 67Ga in the lung and mediastinum was compared with 67Ga uptake in the liver and in the shoulders soft tissue.
PULMONARY SCANNING Pulmonary scanning included: (1) a ventilatory scanning obtained in a sitting position by respiration of gaseous Xenon (1 mCi/l) which provided a steady state ventilation picture, the total lung height and a recording of lung emptying at one minute. The pulmonary gas retention was estimated by the percentage of gas remaining in the lung at one minute. The distribution of gaseous Xenon was pictured so that a 'centre of gravity' or 'barycentre' of the lung ventilation could be determined. Radiation exposure was: 8-3 mRad for lungs, 0-09 mRad for whole body. (2) a perfusion scanning after slow intravenous infusion of Technetium albumin macroaggregates in a sitting position (1 mCi). Abnormal distribution of lung perfusion was detected as well as the vertical perfusion gradient from the top to the lung basis. The distribution of macroaggregates was recorded so that a 'centre of gravity' of the lung perfusion could be determined. (3) the distance delta(A) between the two 'centre of gravity' was determined and expressed as percentage of the total lung height.
BLOOD TESTS
Serum angiotensin-converting enzyme assay was carried out in all patients3 as well as beta-2-microglobulin34 and circulating immune complexes by 121-I-Clq binding activity and by polyethylene glycol precipitation technique.
STATISTICAL METHODS
Results were expressed as mean value (m) ± one standard deviation. The two-tailed t test was used for comparison of data between patients and controls.
Results
All patients were free of clinical pulmonary symptoms and had normal chest radiograph findings. 
